| 489428 |
BMJ OPEN |
Preoperative bariatric surgery programme barriers facing Pacific patients in Auckland, New Zealand as perceived by health sector professionals: a qualitative study |
2019-11-01 |
10.1136/bmjopen-2019-029525 |
Taylor Tamasin, Wrapson Wendy, Dewes Ofa, Taufa Nalei, Siegert Richard J |
| 489427 |
BIOMOLECULES & THERAPEUTICS |
S1P1 Regulates M1/M2 Polarization toward Brain Injury after Transient Focal Cerebral Ischemia |
2019-11-01 |
10.4062/biomolther.2019.005 |
Gaire, Bhakta Prasad, Bae, Young Joo, Choi, Ji Woong |
| 489426 |
ONCOTARGETS AND THERAPY |
Inhibition Of Glycogen Synthase Kinase 3 Beta Suppresses The Growth And Survival Of Skull Base Chordoma Cells By Downregulating Brachyury Expression |
2019-11-01 |
10.2147/ott.s218930 |
Yan Xudong, Li Zhiyuan, Li Hong, Liu Pei, Zhao Zehang, Cheng Shan, Wang Zhenlin, Zhang Qiuhang |
| 489425 |
CANCER MANAGEMENT AND RESEARCH |
Undifferentiated Pleomorphic Sarcoma: Long-Term Follow-Up from a Large Institution |
2019-11-01 |
10.2147/cmar.s226896 |
Chen Shiqi, Huang Wending, Luo Peng, Cai Weiluo, Yang Lingge, Sun Zhengwang, Zheng Biqiang, Yan Wangjun, Wang Chunmeng |
| 489424 |
NEURO-ONCOLOGY |
SURG-22. CUSHING’S DISEASE: A DIFFICULT TO TREAT NEURO-ONCOLOGICAL CONDITION |
2019-11-01 |
10.1093/neuonc/noz175.1022 |
Bora Santanu, Suri Ashish |
| 489423 |
NEURO-ONCOLOGY |
RTHP-39. SPINAL CORD DELINEATION BASED ON CT MYELOGRAM VERSUS T2 MRI IN SPINE SBRT CASES |
2019-11-01 |
10.1093/neuonc/noz175.910 |
Hammoudeh Lubna, Young Lee Ho, Guenette Jeffrey, Balboni Tracy |
| 489422 |
NEURO-ONCOLOGY |
RTHP-11. THE EFFECT OF PRESCRIPTION ISODOSE LINE ON LOCAL CONTROL AND RADIOGRAPHIC RESPONSE IN GAMMA KNIFE RADIOSURGERY OF VESTIBULAR SCHWANNOMA |
2019-11-01 |
10.1093/neuonc/noz175.884 |
Teyateeti Achiraya, Graffeo Christopher, Perry Avital, Brown Paul, Pollock Bruce, Michael Link |
| 489421 |
NEURO-ONCOLOGY |
ATIM-22. PHASE I TRIAL OF DRUG RESISTANT IMMUNOTHERAPY: A FIRST-IN-CLASS COMBINATION OF MGMT-MODIFIEDγδ T CELLS AND TEMOZOLOMIDE CHEMOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME | ATIM-22. PHASE I TRIAL OF DRUG RESISTANT IMMUNOTHERAPY: A FIRST-IN-C |
2019-11-01 |
10.1093/neuonc/noz175.021 |
Lamb Lawrence, Markert James, Yancey Gillespie G, Beelen Melissa, Langford Catherine, Pereboeva Larisa, Youngblood Samantha, Nabors Louis |
| 489420 |
NEURO-ONCOLOGY |
CSIG-16. RECONCILING TUMOR HETEROGENEITY IN GLIOBLASTOMA USING A PATHWAY-BASED APPROACH | CSIG-16. RECONCILING TUMOR HETEROGENEITY IN GLIOBLASTOMA USING A PATHWAY-BASED APPROACH |
2019-11-01 |
10.1093/neuonc/noz175.186 |
Alvarado Alvaro, Kawaguchi Riki, Coppola Giovanni, Goldman Steven, Kornblum Harley |
| 489419 |
NEURO-ONCOLOGY |
GENE-54. INVESTIGATING THE ROLES OF NCOR1 AND NCOR2 IN METASTATIC INVASION INTO THE SPINE | GENE-54. INVESTIGATING THE ROLES OF NCOR1 AND NCOR2 IN METASTATIC INVASION INTO THE SPINE |
2019-11-01 |
10.1093/neuonc/noz175.456 |
Sultan Zain, Rocco Sabrina, Szerlip Nicholas, Calinescu Alexandra |
